Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Everest Medicines (beijing) Co., Ltd.

Clinical trials sponsored by Everest Medicines (beijing) Co., Ltd., explained in plain language.

Now part of Everest Medicines Limited 1952 HKEX

A subsidiary of Everest Medicines, a biopharmaceutical company developing innovative drugs for Asia.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

New combo therapy aims to shrink Hard-to-Treat tumors

Disease control Recruiting now

This early-stage trial tests a new drug called EVM14, given alone or with an immunotherapy (pembrolizumab), in people with advanced solid tumors that have spread or come back. The main goals are to check safety, find the right dose, and see if the drug helps control the cancer. A…

Phase: PHASE1, PHASE2 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC